New study aims to predict dangerous blood clots in cancer patients on chemo

NCT ID NCT07196020

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

Cancer patients face a higher risk of blood clots during chemotherapy, but it's hard to know who is most at risk. This study will measure clotting-related biomarkers in the blood of 380 patients with ovarian, lung, stomach, or pancreatic cancer at four points during their treatment. By comparing those who develop clots with those who don't, researchers hope to develop a blood test that predicts clot risk and helps guide the safe use of blood thinners.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a simple blood test that identifies which cancer patients are at high risk of blood clots during chemotherapy, allowing doctors to use blood thinners more safely and effectively.
What could go wrong
This is an observational study, not a treatment trial. It is still in early stages and may not produce a reliable prediction tool. The results may not apply to all cancer types or treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cork University Hospital

    RECRUITING

    Cork, Ireland, T12 DC4A, Ireland

  • Mater Misericordiae University Hospital

    RECRUITING

    Dublin, Ireland, D07R2WY, Ireland

  • Trinity Cancer St. James Cancer Institute

    RECRUITING

    Dublin, Ireland, D08W9RT, Ireland

More trials for these conditions

Other studies related to the condition(s) this trial covers.